相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Hyperglycemic environment disrupts phosphate transporter function and promotes calcification processes in podocytes and isolated glomeruli
Tomasz Kulesza et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2022)
Enhancement of cGMP-dependent pathway activity ameliorates hyperglycemia-induced decrease in SIRT1-AMPK activity in podocytes: Impact on glucose uptake and podocyte function
Dorota Rogacka et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2022)
SIRT1-mediated deacetylation of NF-κB inhibits the MLCK/MLC2 pathway and the expression of ET-1, thus alleviating the development of coronary artery spasm
Bo-Wen Wu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2021)
Insulin resistance in glomerular podocytes: Potential mechanisms of induction
Dorota Rogacka
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2021)
Involvement of nitric oxide synthase/nitric oxide pathway in the regulation of SIRT1-AMPK crosstalk in podocytes: Impact on glucose uptake
Dorota Rogacka et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2021)
Metformin reduces TRPC6 expression through AMPK activation and modulates cytoskeleton dynamics in podocytes under diabetic conditions
Maria Szrejder et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Cathepsin C is a novel mediator of podocyte and renal injury induced by hyperglycemia
Irena Audzeyenka et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2020)
Tadalafil improves bladder dysfunction and object recognition in rats with pelvic venous congestion
Saori Nishijima et al.
INTERNATIONAL JOURNAL OF UROLOGY (2019)
Hyperglycemia-Driven Inhibition of AMP-Activated Protein Kinase α2 Induces Diabetic Cardiomyopathy by Promoting Mitochondria-Associated Endoplasmic Reticulum Membranes In Vivo
Shengnan Wu et al.
CIRCULATION (2019)
PDE5A Suppresses Proteasome Activity Leading to Insulin Resistance in C2C12 Myotubes
Wei Liu et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2019)
Metformin overcomes high glucose-induced insulin resistance of podocytes by pleiotropic effects on SIRT1 and AMPK
Dorota Rogacka et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
PDE5 inhibitors - pharmacology and clinical applications 20 years after sildenafil discovery
K-E Andersson
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Identification of Core Gene Biomarkers in Patients with Diabetic Cardiomyopathy
Ning Li et al.
DISEASE MARKERS (2018)
The phosphodiesterase 5 inhibitor tadalafil regulates lipidic homeostasis in human skeletal muscle cell metabolism
F. Marampon et al.
ENDOCRINE (2018)
Sildenafil Prevents Podocyte Injury via PPAR-γ-Mediated TRPC6 Inhibition
Ramon Sonneveld et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Mechanistic Insight and Management of Diabetic Nephropathy: Recent Progress and Future Perspective
Rui Xue et al.
JOURNAL OF DIABETES RESEARCH (2017)
SIRT1-AMPK crosstalk is involved in high glucose-dependent impairment of insulin responsiveness in primary rat podocytes
Dorota Rogacka et al.
EXPERIMENTAL CELL RESEARCH (2016)
PDE5 Inhibition Ameliorates Visceral Adiposity Targeting the miR-22/SIRT1 Pathway: Evidence From the CECSID Trial
Daniela Fiore et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Phosphodiesterase Type 5 Inhibition Reduces Albuminuria in Subjects with Overt Diabetic Nephropathy
Wim Scheele et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Tadalafil reduces visceral adipose tissue accumulation by promoting preadipocytes differentiation towards a metabolically healthy phenotype: Studies in rabbits
Elena Maneschi et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2016)
Tadalafil Integrates Nitric Oxide-Hydrogen Sulfide Signaling to Inhibit High Glucose-induced Matrix Protein Synthesis in Podocytes
Hak Joo Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer
Anindita Das et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Tadalafil, a Phosphodiesterase Inhibitor Protects Stem Cells over Longer Period Against Hypoxia/Reoxygenation Injury Through STAT3/PKG-I Signaling
Sanjay Kumar et al.
STEM CELLS AND DEVELOPMENT (2015)
Chronic inhibition of phosphodiesterase 5 with tadalafil attenuates mitochondrial dysfunction in type 2 diabetic hearts: potential role of NO/SIRT1/PGC-1α signaling
Saisudha Koka et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2014)
Insulin stimulates glucose transport via protein kinase G type I alpha-dependent pathway in podocytes
Agnieszka Piwkowska et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
High glucose increases glomerular filtration barrier permeability by activating protein kinase G type Ice subunits in a Nox4-dependent manner
Agnieszka Piwkowska et al.
EXPERIMENTAL CELL RESEARCH (2014)
Involvement of the AMPK-PTEN pathway in insulin resistance induced by high glucose in cultured rat podocytes
Dorota Rogacka et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Antenatal maternally-administered phosphodiesterase type 5 inhibitors normalize eNOS expression in the fetal lamb model of congenital diaphragmatic hernia
Eveline H. Shue et al.
JOURNAL OF PEDIATRIC SURGERY (2014)
Effectiveness and Safety of Phosphodiesterase 5 Inhibitors in Patients with Cardiovascular Disease and Hypertension
Steven G. Chrysant
CURRENT HYPERTENSION REPORTS (2013)
Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3′,5′ guanosine monophosphate (cGMP) level in podocytes
Lilla Fang et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Re-scan confocal microscopy: scanning twice for better resolution
Giulia M. R. De Luca et al.
BIOMEDICAL OPTICS EXPRESS (2013)
Phosphodiesterase-5 inhibition attenuates early renal ischemia-reperfusion-induced acute kidney injury: assessment by quantitative measurement of urinary NGAL and KIM-1
Rima Sohotnik et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)
Chronic Inhibition of cGMP Phosphodiesterase 5A Improves Diabetic Cardiomyopathy A Randomized, Controlled Clinical Trial Using Magnetic Resonance Imaging With Myocardial Tagging
Elisa Giannetta et al.
CIRCULATION (2012)
Hydrogen peroxide induces dimerization of protein kinase G type Iα subunits and increases albumin permeability in cultured rat podocytes
Agnieszka Piwkowska et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Effects of Experimental Hyperlipidemia on the Pharmacokinetics of Tadalafil in Rats
Joo Hyun Lee et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2012)
Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in non-insulin-dependent Otsuka Long-Evans Tokushima Fatty rats
Yoshihiro Kuno et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
The role of metabolic and haemodynamic factors in podocyte injury in diabetes
Nicole Stieger et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2011)
PHOSPHODIESTERASE-5 IS A THERAPEUTIC TARGET FOR PERIPHERAL NEUROPATHY IN DIABETIC MICE
L. Wang et al.
NEUROSCIENCE (2011)
The Beneficial Effects of Tadalafil on Renal Ischemia-Reperfusion Injury in Rats
Mehmet Guzeloglu et al.
UROLOGIA INTERNATIONALIS (2011)
Downregulation of the Longevity-Associated Protein Sirtuin 1 in Insulin Resistance and Metabolic Syndrome: Potential Biochemical Mechanisms
Saula Vigili de Kreutzenberg et al.
DIABETES (2010)
Tadalafil increases muscle capillary recruitment and forearm glucose uptake in women with type 2 diabetes
P. -A. Jansson et al.
DIABETOLOGIA (2010)
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
Sharron H. Francis et al.
PHARMACOLOGICAL REVIEWS (2010)
Effects of Sildenafil on Oxidative and Inflammatory Injuries of the Kidney in Streptozotocin-Induced Diabetic Rats
Kyung-Hwan Jeong et al.
AMERICAN JOURNAL OF NEPHROLOGY (2009)
Concurrent regulation of AMP-activated protein kinase and SIRT1 in mammalian cells
Gabriela Suchankova et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Metabolic benefits from Sirt1 and Sirt1 activators
Nilika Chaudhary et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2009)
NO targets SIRT1 - A novel signaling network in endothelial senescence
Michael Potente et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production
Sharma Prabhakar et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Nitric oxide increases GLUT4 expression and regulates AMPK signaling in skeletal muscle
Vitor A. Lira et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Increased renal phosphodiesterase-5 activity mediates the blunted natriuretic response to ANP in the pregnant rat
Sarah Knight et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Spectrum of renal diseases associated with extreme forms of insulin resistance
Carla Musso et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage
B Rodríguez-Iturbe et al.
KIDNEY INTERNATIONAL (2005)
The human glomerular podocyte is a novel target for insulin action
RJM Coward et al.
DIABETES (2005)
Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS
E Nisoli et al.
SCIENCE (2005)
Mechanism of human SIRT1 activation by resveratrol
MT Borra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Insight on the Pathogenesis of Diabetic Nephropathy from the Study of Podocyte and Mesangial Cell Biology
Gabriella Gruden et al.
CURRENT DIABETES REVIEWS (2005)
cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism
E Takimoto et al.
CIRCULATION RESEARCH (2005)
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism
BB Kahn et al.
CELL METABOLISM (2005)
Characterization of glucose uptake by cultured rat podocytes
B Lewko et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2005)
Glueose autoregulates its uptake in skeletal muscle - Involvement of AMP-activated protein kinase
SI Itani et al.
DIABETES (2003)
ATP induces intracellular calcium increases and actin cytoskeleton disaggregation via P2x receptors
D Pubill et al.
CELL CALCIUM (2001)